Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Blood Coagulation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00004058
What this trial is testing

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Medicine and Dentistry of New Jersey
Not applicableEnded earlyNCT00340548
What this trial is testing

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Who this might be right for
HemophiliaAIDS
National Cancer Institute (NCI) 333
Testing effectiveness (Phase 2)Study completedNCT00717626
What this trial is testing

Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia A

Who this might be right for
Hemophilia A
The Hospital for Sick Children 14
Testing effectiveness (Phase 2)Study completedNCT03307980
What this trial is testing

Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 21
Large-scale testing (Phase 3)Ended earlyNCT00306670
What this trial is testing

Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A

Who this might be right for
Hemophilia A
Georgetown University 2
Testing effectiveness (Phase 2)UnknownNCT05281068
What this trial is testing

The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
ITPImmune Thrombocytopenia
Peking University People's Hospital 120
Testing effectiveness (Phase 2)Study completedNCT00123591
What this trial is testing

Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury

Who this might be right for
Acquired Bleeding DisorderTrauma
Novo Nordisk A/S 96
Not applicableUnknownNCT05939960
What this trial is testing

Application of a New Type of Whole Blood Coagulation Time Measurement in Evaluating the Hypercoagulable State of Malignant Tumors

Who this might be right for
Neoplasm MetastasisBlood Coagulation Disorder With Shortened Coagulation Time (Disorder)Venous Thromboembolism
Tianjin Medical University General Hospital 354
Very early researchStudy completedNCT03272568
What this trial is testing

Extended Half Life Factor (EHF) Products For Heavy Menstrual Bleeding in Hemophilia Carriers

Who this might be right for
HemophiliaMenstrual Flow Excessive
Emory University 3
Not applicableUnknownNCT01815190
What this trial is testing

IgA-positive Versus IgA-negative Immune Complex Vasculitis

Who this might be right for
Cutaneous Vasculitis
University Hospital Muenster 300
Not applicableStudy completedNCT04387942
What this trial is testing

The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 in Children With Henoch-schönlein Purpura

Who this might be right for
Purpura, Schoenlein-Henoch
The First Hospital of Jilin University 59
Not applicableLooking for participantsNCT06590974
What this trial is testing

Freeze-dried Human Protein C Concentrate (TAK-662) in Participants With Congenital Protein C Deficiency

Who this might be right for
Protein C Deficiency
Takeda 7
Not applicableStudy completedNCT03685097
What this trial is testing

Comparison of Two Point-of-care Devices for Viscoelastic Hemostasis Assays

Who this might be right for
Coagulation Disorder
HemoSonics LLC 30
Not applicableLooking for participantsNCT06361641
What this trial is testing

Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes

Who this might be right for
Myeloproliferative NeoplasmPolycythemia VeraEssential Thrombocythemia+1 more
University Hospital, Angers 70
Not applicableStudy completedNCT06212505
What this trial is testing

EVALUATION of the OVERALL HAEMOSTATIC CAPACITY of MIM8 with GLOBAL HAEMOSTASIS ASSAYS and FIBRIN CLOT ULTRASTRUCTURE

Who this might be right for
Hemophilia a
Hospices Civils de Lyon 6
Not applicableStudy completedNCT00557908
What this trial is testing

The Von Willebrand Disease (VWD) International Prophylaxis Study

Who this might be right for
Von Willebrand Disease
Skane University Hospital 105
Post-approval studies (Phase 4)Study completedNCT00950170
What this trial is testing

Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care Setting

Who this might be right for
Hemophilia A
Pfizer 23
Post-approval studies (Phase 4)Study completedNCT04360824
What this trial is testing

Covid-19 Associated Coagulopathy

Who this might be right for
COVID 19 Associated Coagulopathy
University of Iowa 176
Not applicableLooking for participantsNCT04942080
What this trial is testing

Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)

Who this might be right for
Myeloproliferative NeoplasmEssential ThrombocythemiaPrimary Myelofibrosis, Prefibrotic Stage+1 more
University Hospital, Angers 260
Early research (Phase 1)Study completedNCT05152420
What this trial is testing

Study of Intravenous VMX-C001 in Healthy Subjects and in Combination With Selected Direct Oral Anticoagulants in Healthy Older Subjects

Who this might be right for
Coagulation Disorder
VarmX B.V. 105
Next Page